1. Home
  2. LSBK vs ADVM Comparison

LSBK vs ADVM Comparison

Compare LSBK & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSBK
  • ADVM
  • Stock Information
  • Founded
  • LSBK 1891
  • ADVM 2006
  • Country
  • LSBK United States
  • ADVM United States
  • Employees
  • LSBK N/A
  • ADVM N/A
  • Industry
  • LSBK Savings Institutions
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LSBK Finance
  • ADVM Health Care
  • Exchange
  • LSBK Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • LSBK 90.0M
  • ADVM 94.6M
  • IPO Year
  • LSBK 2006
  • ADVM 2014
  • Fundamental
  • Price
  • LSBK $13.01
  • ADVM $4.84
  • Analyst Decision
  • LSBK
  • ADVM Strong Buy
  • Analyst Count
  • LSBK 0
  • ADVM 4
  • Target Price
  • LSBK N/A
  • ADVM $19.75
  • AVG Volume (30 Days)
  • LSBK 21.9K
  • ADVM 725.5K
  • Earning Date
  • LSBK 10-22-2025
  • ADVM 11-03-2025
  • Dividend Yield
  • LSBK 2.77%
  • ADVM N/A
  • EPS Growth
  • LSBK 39.59
  • ADVM N/A
  • EPS
  • LSBK 1.05
  • ADVM N/A
  • Revenue
  • LSBK $26,488,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • LSBK N/A
  • ADVM $1,836.70
  • Revenue Next Year
  • LSBK N/A
  • ADVM N/A
  • P/E Ratio
  • LSBK $12.38
  • ADVM N/A
  • Revenue Growth
  • LSBK 1.75
  • ADVM N/A
  • 52 Week Low
  • LSBK $11.50
  • ADVM $1.78
  • 52 Week High
  • LSBK $13.48
  • ADVM $8.56
  • Technical
  • Relative Strength Index (RSI)
  • LSBK 47.09
  • ADVM 64.48
  • Support Level
  • LSBK $12.88
  • ADVM $4.01
  • Resistance Level
  • LSBK $13.09
  • ADVM $5.58
  • Average True Range (ATR)
  • LSBK 0.14
  • ADVM 0.63
  • MACD
  • LSBK -0.00
  • ADVM 0.10
  • Stochastic Oscillator
  • LSBK 26.00
  • ADVM 69.05

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: